Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

chemosensitization

  • You have access
    Chemosensitizing Effects of Resveratrol Derivatives on p53-dependent Apoptosis Triggered by Cisplatin in Human Lung Cancer Cells
    THANAWUT PRAMUALSIN, ZIN ZIN EI, SATAPAT RACHA, NICHARAT SRIRATANASAK, MASASHI YOKOYA, YUKIHA IIDA and PITHI CHANVORACHOTE
    Anticancer Research April 2026, 46 (4) 1893-1901; DOI: https://doi.org/10.21873/anticanres.18082
  • You have access
    Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells
    MARTA MICHALSKA, SUSANNE SCHULTZE-SEEMANN, IRINA KUCKUCK, ARNDT KATZENWADEL and PHILIPP WOLF
    Anticancer Research March 2018, 38 (3) 1369-1375;
  • You have access
    Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine
    HIROYUKI TAKEDA, MASASHI OKADA, SHUHEI SUZUKI, KENTA KURAMOTO, HIROTSUGU SAKAKI, HIKARU WATARAI, TOMOMI SANOMACHI, SHIZUKA SEINO, TAKASHI YOSHIOKA and CHIFUMI KITANAKA
    Anticancer Research December 2016, 36 (12) 6311-6318;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire